ENTITY

Ainos (AIMD US)

10
Analysis
Health CareUnited States
Ainos, Inc. is a diversified healthcare company. The Company engages in the discovery and development of novel biopharmaceuticals, technologically medical treatments, and consumer products, as well as provides treatments of neoplastic, viral, and autoimmune diseases. Ainos operates in the United States and Taiwan.
more
bullishAinos
13 Nov 2024 19:39Issuer-paid

Ainos, Inc.: IRB Approval for Veldona Sjogren's Trial

Ainos received Institutional Review Board (IRB) approval from the Shuang Ho Hospital (Taipei Medical University) to conduct the Veldona clinical...

Logo
111 Views
Share
bullishAinos
25 Oct 2024 18:34Issuer-paid

Ainos, Inc: WTR Small-Cap Spotlight Recap - Veldona Drug Platform and Clinical Studies

Jack Lu, Director of Corporate Development, joined us on the WTR Small-Cap Spotlight podcast to discuss Veldona, Ainos’ clinical stage low-dose...

Logo
308 Views
Share
bullishAinos
25 Sep 2024 07:39Issuer-paid

Ainos, Inc. - Veldona Sjogren's Study Start to Quickly Follow Oral Warts

Taiwan Veldona human study to start in Sjogren’s. Ainos will initiate a Veldona clinical study in Taiwan for primary Sjogren’s syndrome in December...

Logo
208 Views
Share
bullishAinos
24 Sep 2024 05:45Issuer-paid

Ainos, Inc. - Veldona Oral Warts Trial to Start in Taiwan Before Year-End

Veldona study design under review by TFDA. Ainos plans to initiate a Veldona clinical study in Taiwan for oral warts in HIV+ patients on...

Logo
13 Views
Share
bullishAinos
05 Sep 2024 18:32Issuer-paid

Ainos, Inc. - Adding Coronavirus Treatment and Prevention to Veldona Patent Portfolio

Veldona patent granted in Taiwan for treatment and prevention of coronavirus infection, securing 20 years of patent protection.

Logo
154 Views
Share
x